CISATRACURIUM (CISATRACURIUM BESYLATE) — all Canadian products
14 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CISATRACURIUM (CISATRACURIUM BESYLATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02423782 | CISATRACURIUM BESYLATE INJECTION MULTI-DOSE | FRESENIUS KABI CANADA LTD | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Approved | |
| 02423774 | CISATRACURIUM BESYLATE INJECTION SINGLE DOSE | FRESENIUS KABI CANADA LTD | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Approved | |
| 02563266 | CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE | STERIMAX INC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Marketed | |
| 02408813 | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE | OMEGA LABORATORIES LIMITED | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Marketed | |
| 02557665 | CISATRACURIUM BESYLATE INJECTION, USP MULTI-DOSE | HIKMA CANADA LIMITED | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Approved | |
| 02408856 | AJ-CISATRACURIUM | AGILA JAMP CANADA INC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market | |
| 02408848 | AJ-CISATRACURIUM | AGILA JAMP CANADA INC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market | |
| 02425718 | CISATRACURIUM BESYLATE INJECTION | PFIZER CANADA ULC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Post Market | |
| 02457385 | CISATRACURIUM BESYLATE INJECTION | ACCORD HEALTHCARE INC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market | |
| 02406519 | CISATRACURIUM BESYLATE INJECTION | MYLAN PHARMACEUTICALS ULC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market | |
| 02406527 | CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE-FREE) | MYLAN PHARMACEUTICALS ULC | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Pre Market | |
| 02408805 | CISATRACURIUM OMEGA SINGLE DOSE | OMEGA LABORATORIES LIMITED | Solution | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Dormant | |
| 02229422 | NIMBEX | ABBVIE CORPORATION | Liquid | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG | Cancelled Post Market | |
| 02229423 | NIMBEX 10MG/ML | ABBOTT LABORATORIES, LIMITED | Liquid | Intravenous | CISATRACURIUM (CISATRACURIUM BESYLATE) 10 MG | Cancelled Post Market |
Browse other molecules: